LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Cost of Revenue in USD from Q1 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: Lixte Biotechnology Holdings, Inc. quarterly Cost of Revenue history and growth rate from Q1 2022 to Q3 2023.
Lixte Biotechnology Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $356K, a 44.7% decline year-over-year.

Cost of Revenue, Quarterly (USD)

Cost of Revenue, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023		$356K	-$288K	-44.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023		$523K	-$231K	-30.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-09
Q1 2023		$519K	-$46.4K	-8.21%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-10
Q3 2022		$644K			Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022		$754K			Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022		$566K			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.